[Federal Register Volume 62, Number 115 (Monday, June 16, 1997)]
[Page 32620]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15761]



Food and Drug Administration

Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Psychopharmacologic Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on July 14, 1997, 8:30 a.m. 
to 5 p.m.
    Location: Holiday Inn, Grand Ballroom, Two Montgomery Village Ave., 
Gaithersburg, MD.
    Contact Person: Rhonda W. Stover or Robinette Taylor, Center for 
Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12544. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The committee will consider proposals to reduce the 
frequency of required white blood cell count monitoring for 
Clozaril (clozapine), new drug application (NDA) 19-758, 
Sandoz Pharmaceutical Corp.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by July 7, 1997. 
Oral presentations from the public will be scheduled between 
approximately 8:30 a.m. and 9:30 a.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before July 7, 1997, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 9, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations
[FR Doc. 97-15761 Filed 6-13-97; 8:45 am]